Credit Suisse Downgrades Mindray Medical (MR) to Neutral
Tweet Send to a FriendGet Alerts MR Hot Sheet
Price: $41.27 --0%
Rating Summary:
5 Buy, 9 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 8
Rating Summary:
5 Buy, 9 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 8
Trade MR Now!
Credit Suisse downgraded Mindray Medical (NYSE: MR) from Outperform to Neutral.
For an analyst ratings summary and ratings history on Mindray Medical click here. For more ratings news on Mindray Medical click here.
Shares of Mindray Medical closed at $33.01 yesterday, with a 52 week range of $25.56-$36.36.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Mindray Medical click here. For more ratings news on Mindray Medical click here.
Shares of Mindray Medical closed at $33.01 yesterday, with a 52 week range of $25.56-$36.36.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Exane BNP Paribas Downgrades BlackBerry (BBRY) to Underperform; Analyst Says Profit 'Drying Up'
- Albert Fried Downgrades Pandora (P) to Market Perform
- UPDATE: Sterne Agee Downgrades Beazer Homes (BZH) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
Credit Suisse
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
